Reach Global Payers Where They Are

December 28, 2016Case Study

When designing new drugs, pharmaceutical companies need to seek the input of key stakeholders – physicians, patients, payers. The goal is to achieve greater information exchange and data-mining capabilities about several key factors, including strategies payers employ to determine therapies and/or rein in costs.

The following case study illustrates how a pharmaceutical company engaged global payers to understand their pharmacologic and financial formulary criteria, and to leverage those findings to help design a new clinical trial and determine the viability of a new treatment.

For specific topics like we had for this board, the virtual format was perfect!

Virtual Ad Board Participant